Agile Therapeutics Inc (AGRX) Stock: Aisling Capital Unloads 300,000 Shares

Page 9 of 9

Page 9 of 9 – SEC Filing
CUSIP No. 00847L100
SCHEDULE 13D
Page 11 of 11
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: October 3, 2016
AISLING CAPITAL III, LP
By:
Aisling Capital Partners III, LP
General Partner
By:
Aisling Capital Partners III LLC
General Partner
By:
/s/ Dennis Purcell
Name: Dennis Purcell
Title: Managing Member
AISLING CAPITAL PARTNERS III, LP
By:
Aisling Capital Partners III LLC
General Partner
By:
/s/ Dennis Purcell
Name: Dennis Purcell
Title: Managing Member
AISLING CAPITAL PARTNERS III LLC
By:
/s/ Dennis Purcell
Name: Dennis Purcell
Title: Managing Member
/s/ Steven Elms
Steven Elms
/s/ Dennis Purcell
Dennis Purcell
/s/ Andrew Schiff
Andrew Schiff
Attention. Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

Follow Agile Therapeutics Inc (NASDAQ:AGRX)

Page 9 of 9